Worldwide prescription drug revenue - market risk from patent expiration 2020-2028

Published by
Matej Mikulic,
Oct 24, 2022
This statistic depicts the share of worldwide prescription drug revenue at risk due to patent expirations from 2020 to 2028. In 2021, less than one percent of the market was at risk due to patent expirations on pharmaceutical drug revenues.

Share of global prescription drug revenue at risk from patent expiration from 2020 to 2028

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2022

Region

Worldwide

Survey time period

as of August 2022

Supplementary notes

'Total Sales at Risk’ represents the worldwide product sales in the year prior to patent expiry but allocated to the year of expiry. E.g. Plavix had sales of $7.1bn in 2011, this would be shown as ‘At Risk’ in 2012.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical market worldwide "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical market worldwide

Overview

7

Segments

8

Companies

8

R&D, patents, new products

8

Outlook

7

Focus: COVID-19 response

7

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizerNovartis
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu